MPS IVA

Clinical trials for MPS IVA explained in plain language.

Never miss a new study

Get alerted when new MPS IVA trials appear

Sign up with your email to follow new studies for MPS IVA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1

Could a daily shot help kids with rare bone diseases grow?

Disease control Ongoing

This early study tests a daily injection of vosoritide (Voxzogo) in 6 children aged 5 to 10 with MPS IVA or VI, rare conditions that cause growth problems. The main goal is to see if the drug is safe and tolerable over 96 weeks. Researchers will also look at changes in height and…

Matched conditions: MPS IVA

Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC

MPS IVA

Get alerted when new MPS IVA trials appear

Could a daily shot help kids with rare bone diseases grow?